Concepedia

Tijmen van Dam

TV

Statistics

Publications

1

Citations

20

H-Index

1

Active since

2019

Affiliations

University of Amsterdam(Current)

Tijmen van Dam is an author at University of Amsterdam specializing in bcr-abl1 fusion gene, oncology, and kinase inhibitors.

ORCID

Publications per year

2019–2019

1

Publications

1

The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors

Mahnoush Bahjat, Guus de Wilde, Tijmen van Dam et al. · Cell Cycle · 2019 · 20 citations · Full text

, , +17

1–1 of 1